- Home
- GCO vs CDXC Comparison
GCO vs CDXC Comparison
Compare GCO & CDXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCO
- CDXC
- Stock Information
- Founded
- GCO 1924
- CDXC 1999
- Country
- GCO United States
- CDXC United States
- Employees
- GCO N/A
- CDXC N/A
- Industry
- GCO Clothing/Shoe/Accessory Stores
- CDXC Medicinal Chemicals and Botanical Products
- Sector
- GCO Consumer Discretionary
- CDXC Health Care
- Exchange
- GCO Nasdaq
- CDXC Nasdaq
- Market Cap
- GCO 472.3M
- CDXC 415.5M
- IPO Year
- GCO N/A
- CDXC N/A
- Fundamental
- Price
- GCO $40.28
- CDXC $5.94
- Analyst Decision
- GCO Hold
- CDXC Strong Buy
- Analyst Count
- GCO 1
- CDXC 2
- Target Price
- GCO $31.00
- CDXC $8.00
- AVG Volume (30 Days)
- GCO 207.3K
- CDXC 458.5K
- Earning Date
- GCO 03-07-2025
- CDXC 03-05-2025
- Dividend Yield
- GCO N/A
- CDXC N/A
- EPS Growth
- GCO N/A
- CDXC N/A
- EPS
- GCO N/A
- CDXC 0.02
- Revenue
- GCO $2,318,063,000.00
- CDXC $91,668,000.00
- Revenue This Year
- GCO $0.58
- CDXC $18.64
- Revenue Next Year
- GCO $1.75
- CDXC $20.72
- P/E Ratio
- GCO N/A
- CDXC $306.20
- Revenue Growth
- GCO 0.32
- CDXC 9.95
- 52 Week Low
- GCO $23.21
- CDXC $1.36
- 52 Week High
- GCO $44.80
- CDXC $7.97
- Technical
- Relative Strength Index (RSI)
- GCO 49.31
- CDXC 54.82
- Support Level
- GCO $38.99
- CDXC $5.17
- Resistance Level
- GCO $43.00
- CDXC $5.52
- Average True Range (ATR)
- GCO 1.96
- CDXC 0.26
- MACD
- GCO -0.54
- CDXC 0.08
- Stochastic Oscillator
- GCO 26.87
- CDXC 89.66
About GCO Genesco Inc.
Genesco Inc sells footwear, headwear, sports apparel, and accessories. The company has four reportable segments namely Journeys Group, derives maximum revenue which comprised of Journeys, Journeys Kidz, and Little Burgundy retail footwear chains, e-commerce operations, and catalog. Its Schuh Group is comprised of the Schuh retail footwear chain and e-commerce operations. The Johnston & Murphy Group is comprised of Johnston & Murphy retail operations, e-commerce operations, and catalog and wholesale distribution of products under the Johnston & Murphy and Genesco Brands Group. Licensed Brands, comprised of Dockers Footwear, under a license from Levi Strauss & Company.
About CDXC ChromaDex Corporation
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.